To further investigate the possible involvement of the eCB in the formoterol-induced headache mechanism, the eCB system was targeted using inhibitors of the eCB enzymes FAAH and MAGL, as well as an eCB receptor targeting agent. The gene discussed is FAAH; the disease is Headache.